Non-Small-Cell Lung Cancer

Category: Medical

ASO Keyword Dashboard

Tracking 44 keywords for Non-Small-Cell Lung Cancer in Apple App Store

Developer: Med Learning Group Category: medical

Non-Small-Cell Lung Cancer tracks 44 keywords (1 keyword ranks; 43 need traction). Key metrics: 0% top-10 coverage, opportunity 70.4, difficulty 38.1, best rank 57.

Tracked keywords

1 ranked • 43 not ranking yet

Top 10 coverage

Best rank 57 • Latest leader —

Avg opportunity

70.4

Top keyword: continue

Avg difficulty

38.1

Lower scores indicate easier wins

Opportunity leaders

continue

Opportunity: 73.0 • Difficulty: 41.3 • Rank —

Competitors: 99
68.5
improved

Opportunity: 73.0 • Difficulty: 38.8 • Rank —

Competitors: 65
64.0
natural

Opportunity: 73.0 • Difficulty: 41.3 • Rank —

Competitors: 99
68.6
target

Opportunity: 73.0 • Difficulty: 40.1 • Rank —

Competitors: 62
66.3
known

Opportunity: 73.0 • Difficulty: 41.1 • Rank —

Competitors: 94
67.9

Unranked opportunities

continue

Opportunity: 73.0 • Difficulty: 41.3 • Competitors: 99
improved

Opportunity: 73.0 • Difficulty: 38.8 • Competitors: 65
natural

Opportunity: 73.0 • Difficulty: 41.3 • Competitors: 99
target

Opportunity: 73.0 • Difficulty: 40.1 • Competitors: 62
known

Opportunity: 73.0 • Difficulty: 41.1 • Competitors: 94

High competition keywords

using

Total apps: 116,675 • Major competitors: 769

Latest rank: — • Difficulty: 51.3
whether

Total apps: 91,914 • Major competitors: 597

Latest rank: — • Difficulty: 50.3
making

Total apps: 55,538 • Major competitors: 389

Latest rank: — • Difficulty: 48.0
various

Total apps: 49,297 • Major competitors: 331

Latest rank: — • Difficulty: 47.4
well

Total apps: 44,343 • Major competitors: 255

Latest rank: — • Difficulty: 46.9

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
non	71	100	35	57 2,500 competing apps Median installs: 50 Avg rating: 4.2	57	57	35 major competitor apps
whether	67	100	50	83 91,914 competing apps Median installs: 25 Avg rating: 4.3	—	—	597 major competitor apps
medical	71	100	43	72 18,736 competing apps Median installs: 25 Avg rating: 4.1	—	—	53 major competitor apps
management	69	100	47	77 41,446 competing apps Median installs: 25 Avg rating: 4.1	—	—	141 major competitor apps
avoid	72	100	43	71 17,568 competing apps Median installs: 75 Avg rating: 4.1	—	—	179 major competitor apps
using	66	100	51	85 116,675 competing apps Median installs: 50 Avg rating: 4.0	—	—	769 major competitor apps
variety	69	100	47	77 39,090 competing apps Median installs: 75 Avg rating: 4.2	—	—	483 major competitor apps
program	72	100	43	71 17,021 competing apps Median installs: 50 Avg rating: 4.1	—	—	116 major competitor apps
various	69	100	47	79 49,297 competing apps Median installs: 50 Avg rating: 4.1	—	—	331 major competitor apps
continue	73	100	41	68 12,154 competing apps Median installs: 75 Avg rating: 4.1	—	—	99 major competitor apps
main	71	100	43	72 20,115 competing apps Median installs: 50 Avg rating: 4.1	—	—	104 major competitor apps
look	69	100	46	76 36,651 competing apps Median installs: 75 Avg rating: 4.1	—	—	377 major competitor apps
well	69	100	47	78 44,343 competing apps Median installs: 50 Avg rating: 4.1	—	—	255 major competitor apps
addition	72	100	42	69 12,719 competing apps Median installs: 50 Avg rating: 4.1	—	—	95 major competitor apps
improved	73	100	39	64 6,591 competing apps Median installs: 75 Avg rating: 4.1	—	—	65 major competitor apps
system	69	100	46	77 39,924 competing apps Median installs: 25 Avg rating: 4.0	—	—	172 major competitor apps
natural	73	100	41	69 12,400 competing apps Median installs: 50 Avg rating: 4.2	—	—	99 major competitor apps
line	72	100	43	71 17,676 competing apps Median installs: 50 Avg rating: 4.1	—	—	192 major competitor apps
target	73	100	40	66 9,079 competing apps Median installs: 50 Avg rating: 4.1	—	—	62 major competitor apps
types	71	100	44	72 19,933 competing apps Median installs: 50 Avg rating: 4.1	—	—	114 major competitor apps
drive	72	100	42	69 13,336 competing apps Median installs: 50 Avg rating: 3.9	—	—	118 major competitor apps
attack	72	100	38	63 5,388 competing apps Median installs: 125 Avg rating: 4.0	—	—	61 major competitor apps
cell	72	100	36	59 3,475 competing apps Median installs: 75 Avg rating: 4.0	—	—	32 major competitor apps
making	68	100	48	80 55,538 competing apps Median installs: 50 Avg rating: 4.2	—	—	389 major competitor apps
known	73	100	41	68 11,220 competing apps Median installs: 75 Avg rating: 4.1	—	—	94 major competitor apps

App Description

Non-small-cell lung cancer (NSCLC) is 1 of 2 main types of lung cancer. It develops from epithelial cells that line the lung airways and sacs, some of which produce mucus that lubricates and protects the lung. Cancer cells use a variety of ways to avoid the body’s natural defense—the immune system—to continue to grow, invade, and spread. In various types of NSCLC, molecular interactions between PD-1 on our immune system’s T-cells and PD-L1 on cancer cells drive whether or not the body’s immune system will attack a cancer cell. This program will look at the cellular underpinnings of NSCLC, as well as agents—known as checkpoint inhibitors—that target PD-1 or PD-L1 for improved management of this condition.

Users should seek a doctor's advice in addition to using this app and before making any medical decisions